Cargando…
Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates
Phenylketonuria (PKU) is a rare genetic condition caused by inborn error(s) in the gene for the enzyme phenylalanine hydroxylase. Resulting loss of phenylalanine (Phe) metabolism requires strict dietary therapy and/or medication to prevent toxic accumulation of Phe. Novel investigational therapies,...
Autores principales: | Regier, Debra S., Bąk, Agata, Bausell, Heather, O'Reilly, Emer, Cowsert, Lex M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248220/ https://www.ncbi.nlm.nih.gov/pubmed/35782620 http://dx.doi.org/10.1016/j.ymgmr.2022.100855 |
Ejemplares similares
-
Going Into a Community, We Need to Start From Where They’re At: Caregiver and Advocate Perspectives
por: Baker, Zachary
Publicado: (2021) -
Family Caregivers as Advocates
por: Whiting, C Grace
Publicado: (2021) -
Dietary intervention in the management of phenylketonuria: current perspectives
por: Rocha, Júlio César, et al.
Publicado: (2016) -
Evidence- and consensus-based recommendations for the use of
pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018) -
Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase
por: Rocha, Júlio César, et al.
Publicado: (2021)